Figure 2.
PFS and OS rates. Kaplan-Meier curves for PFS (A-B) and OS (C-D) for patients treated with pirtobrutinib-based combination therapies. Tick marks indicate censored data.

PFS and OS rates. Kaplan-Meier curves for PFS (A-B) and OS (C-D) for patients treated with pirtobrutinib-based combination therapies. Tick marks indicate censored data.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal